However, only five individuals with AP2M1 mutations associated with neurodevelopmental disorders have been reported in the literature so far,1, 2 and the few clinical data available suggest that AP2M1 mutations cause a variable phenotype ranging from severe intellectual disability, autism spectrum disorder, and epilepsy to isolated global developmental delay (GDD). Here, AP2M1 is linked to epilepsy.